The aim is to make available over 100 million vaccine dosses to Americans on the first run. and additional 500 million afterwards…
There would be NO cost for the vaccine in the national health interest….
Four vaccines are in the lead…..
The time line is looking at late this year at the earliest ….
Experimental vaccine tests for up to 130,000 Americans will start in a week or so…
There will be several vaccine’s available to the public a year from now….
“Depending on success in clinical trials, today’s agreement will enable the delivery of approximately 100 million doses of this vaccine to the American people,” HHS Secretary Alex Azar said in a news release.
The BNT162 program, based on BioNTech’s mRNA technology and developed by Pfizer, is currently evaluating at least four experimental vaccines in clinical studies. If those studies are successful, the companies will seek the emergency use authorization from the U.S. Food and Drug Administration in October that would allow it to move into the manufacturing phase, the release said.
“We are also in advanced discussions with multiple other government bodies and we hope to announce additional supply agreements soon,” BioNTech chief executive Ugur Sahin said in a news release. “Our goal remains to bring a safe and effective COVID-19 vaccine to many people around the world, as quickly as we can.”
Other companies racing to produce a coronavirus vaccine by the end of 2020 or early 2021 include Johnson & Johnson, Moderna, AstraZenecaand Novavax. The U.S. government’s funding of multiple vaccine candidates allows room for error, in the event that some aren’t effective. But experts say the timeline is ambitious, as developing a successful vaccine is usually a years-long process…..